News

CirrusMD’s Physician-first Virtual Care Now Accessible Via Partnership With Blackwell Captive Solutions, Changing Healthcare Delivery in the U.S.

ful. Health Partners With Blackwell Captive Solutions to Deliver Innovative Cost-Containment Solutions, Featuring CirrusMD's Physician-Led Care, Ensuring Payers Benefit From…

2 years ago

Invitation to Live Presentation of Senzime’s First Quarter 2024 Report

UPPSALA, SWEDEN / ACCESSWIRE / May 2, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast…

2 years ago

Quest Supports Expansion of Community Center and Provides No-Cost Wellness Testing to Newark Faith Community

NORTHAMPTON, MA / ACCESSWIRE / May 2, 2024 / Quest Diagnostics: At a glance:Quest worked with St. James Health in…

2 years ago

Tocca Life Holdings Inc. Announces Exciting Developments in the World of Indoor Rock Climbing

WINTER PARK, FL / ACCESSWIRE / May 2, 2024 / Tocca Life Holdings, Inc. (OTC PINK:TLIF) is thrilled to share…

2 years ago

Theralase(R) Expands Clinical Team

TORONTO, ON / ACCESSWIRE / May 2, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

2 years ago

Bausch Health Announces First Quarter 2024 Results

First quarter revenues of $2.15 billion, up 11% on a Reported and 8% on an Organic1 basisYear-over-year revenue growth in…

2 years ago

Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform

Intellectual property portfolio now includes 188 Patents and 131 Trademarks providing robust protection for the Company's product platforms ANN ARBOR,…

2 years ago

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for…

2 years ago

Planet 13 Announces Release Date of First Quarter 2024 Financial Results

LAS VEGAS, NV / ACCESSWIRE / May 2, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),…

2 years ago

ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics

New research collaboration will explore the differentiation of eblasakimab's mechanism of action versus biologic therapies for atopic dermatitis (AD), dupilumab…

2 years ago